Bella Milagros, Inc is a commercial-stage biotechnology company with fully integrated commercial and business development operations, with a focus in Anti-aging and Regenerative Medicine. Our primary strategy is comprised of research, development, branding and commercializing a broad and diverse pipeline of clinically sound commercial products. In addition to building an efficient in-house research and development organization with superior marketing and branding capabilities, Bella Milagros has established a commercial infrastructure for its marketed products. We also leverage the expertise of our worldwide partners to assist in the execution of our strategy. Our passion to identify, develop and deliver important options for people seeking advanced and clinically sound Anti-aging and Regenerative Medicine products. At Bella Milagros, we are committed to excellence and strive to make a difference in the lives of consumers every day. Mesenchymal Stem Cell and Growth Factor Technology division: 2010 to present R&D: - Seperation Effects of Adipose from Stromal Stem Cells with Centrifusion - Ideal Centrifusion Revolutions and Speed for PRP and PPP - Isotonic Saline Wash of Non-Centrifuged ADSVF in Preparation for Grafting - Isotonic Saline Wash of Centrifuged ADSVF in Preparation for Grafting - DermaLift® Collagen Stimulating Slurry 2015 Project: NanoParticles. Transformation of our nanoparticle research into a self-sustaining business division. Integration of our 50-100nm nanoparticles into our manufacturing process and development of new formulations. 2014: Collagen Restoration Technology division: R&D formulations and clinical studies using 99% pure Tropocollagen 2013: Human Growth Factor R&D formulations for cosmetic application to reduce rhytides and improve skin quality. Develop in house nanoparticles 2012t: Development of DermaLift® 2011: Human Growth Factor R&D formulations for medical application in wound healing